BJP Evidence-Based Mental Health
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

The British Journal of Psychiatry 150: 334-338 (1987)
© 1987 The Royal College of Psychiatrists

The Scottish First Episode Schizophrenia Study. II. Treatment: pimozide versus flupenthixol. The Scottish Schizophrenia Research Group


In a randomised double-blind study, 46 first episode schizophrenics were given pimozide or flupenthixol for up to 5 weeks; the mean daily dose at the end was 18.8 mg pimozide and 20 mg flupenthixol. There were no significant between-drug differences in the effect on mental state or behaviour; positive schizophrenic symptoms responded to treatment, negative symptoms did not. Most patients required anti-Parkinsonian medication. Poor response was associated with 'organicity'. A switch to maintenance therapy after 5 weeks, the outcome of successful treatment and patient cooperation, was achieved in only 54%. There was no relationship between plasma prolactin levels and severity of schizophrenic symptoms in unmedicated patients. Pimozide produced greater elevation of plasma prolactin. Plasma neuroleptic levels showed drug compliance was satisfactory throughout in only 54%.


This article has been cited by other articles:


Home page
 Schizophr BullHome page
D. G Robinson, M. G Woerner, H. M Delman, and J. M Kane
Pharmacological Treatments for First-Episode Schizophrenia
Schizophr Bull, July 1, 2005; 31(3): 705 - 722.
[Abstract] [Full Text] [PDF]

Home page
 FocusHome page
M. Gitlin, K. Nuechterlein, K. L. Subotnik, J. Ventura, J. Mintz, D. L. Fogelson, G. Bartzokis, and M. Aravagiri
Clinical Outcome Following Neuroleptic Discontinuation in Patients With Remitted Recent-Onset Schizophrenia
Focus, January 1, 2004; 2(1): 122 - 130.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
M. Gitlin, K. Nuechterlein, K. L. Subotnik, J. Ventura, J. Mintz, D. L. Fogelson, G. Bartzokis, and M. Aravagiri
Clinical Outcome Following Neuroleptic Discontinuation in Patients With Remitted Recent-Onset Schizophrenia
Am J Psychiatry, November 1, 2001; 158(11): 1835 - 1842.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
S. Kapur, R. Zipursky, C. Jones, G. Remington, and S. Houle
Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia
Am J Psychiatry, April 1, 2000; 157(4): 514 - 520.
[Abstract] [Full Text]

Home page
 Am. J. PsychiatryHome page
D. G. Robinson, M. G. Woerner, J. Ma.J. Alvir, S. Geisler, A. Koreen, B. Sheitman, M. Chakos, D. Mayerhoff, R. Bilder, R. Goldman, et al.
Predictors of Treatment Response From a First Episode of Schizophrenia or Schizoaffective Disorder
Am J Psychiatry, April 1, 1999; 156(4): 544 - 549.
[Abstract] [Full Text]

Home page
 Psychiatr. Serv.Home page
M. Valenstein, K. L. Barry, F. C. Blow, L. Copeland, and E. Ullman
Agreement Between Seriously Mentally Ill Veterans and Their Clinicians About Medication Compliance
Psychiatr Serv, August 1, 1998; 49(8): 1043 - 1048.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1987 The Royal College of Psychiatrists.